• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX

AMPLIA THERAPEUTICS LIMITED

5.00% ! 5.7¢
Market Cap $22.11M  !
Healthcare Biotechnology
Add to My Watchlist

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ATX
Ann: Preliminary Final Report and Annual Report YE 31 March 2025 		14/06/25 9 2.7K
14/06/25 Last post  leveller Comments Created with Sketch.  9  Views Created with Sketch.  2.7K 
ATX
Ann: ACCENT Trial Achieves Superiority over Chemotherapy Alone
2
05/06/25 87 27K
05/06/25 Last post  reon1 Comments Created with Sketch.  87  Views Created with Sketch.  27K 
ATX
Ann: Appendix 4G - Key to Corporate Governance Disclosures 		30/05/25 0 225
30/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  225 
ATX
Ann: 2025 Corporate Governance Statement 		30/05/25 0 201
30/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  201 
ATX
Ann: Change in substantial holding
2
29/05/25 63 17K
29/05/25 Last post  vincenski Comments Created with Sketch.  63  Views Created with Sketch.  17K 
ATX
chart 		16/05/25 1 431
16/05/25 Last post  Amit9997 Comments Created with Sketch.  1  Views Created with Sketch.  431 
ATX
Amplia pops 40% on liquidity surge as chemo combo proves successful 		13:31 0 326
13:31 Last post  ASX Insights Comments Created with Sketch.  0  Views Created with Sketch.  326 
ATX
Ann: Amplia Appoints Dr Jason Lickliter as Chief Medical Officer 		14/05/25 13 3.5K
14/05/25 Last post  Meledath Comments Created with Sketch.  13  Views Created with Sketch.  3.5K 

See All Discussions arrow Created with Sketch.

Timeline

Appendix 4G - Key to Corporate Governance Disclosures
30 May 15:14
 
2025 Corporate Governance Statement
30 May 15:14
 
Preliminary Final Report and Annual Report YE 31 March 2025
30 May 15:13
 
Change in substantial holding
16 May 17:05
 
ACCENT Trial Achieves Superiority over Chemotherapy Alone
15 May 08:21
 
Amplia Appoints Dr Jason Lickliter as Chief Medical Officer
12 May 08:20
 
View More arrow Created with Sketch.

Featured News

NEWS High-Grade Assays Confirm Multiple Parallel Zones at Golden Eye
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
NEWS Vection Launches Algho AI Sign Language on AWS Marketplace Across Europe
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.

Latest Videos

Amplia Therapeutics mints $2.4m R&D tax benefit


20 Oct 2023 10:46 (AEDT)

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
5.7¢ 		Change
-0.003(5.00%) 		Mkt cap ! $22.11M
Open High Low Value Volume
6.1¢ 6.1¢ 5.6¢ $27.87K 490.9K

Buyers (Bids)

No. Vol. Price($)
2 42618 5.7¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 93000 2
View Market Depth
Last trade - 15.58pm 13/06/2025 (20 minute delay) ?
ATX (ASX) Chart

Top Stories

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Advance Metals (ASX:AVM) has started its maiden drilling at the Yoquivo Silver-Gold Project in Mexico with a bang...
HotCopper Highlights, Week 24: Israel boosts Energy; Meeka eyes production & Mag7 back Good Afternoon and welcome to HotCopper Highlights for Week 24 of the year, I’m Jon Davidson. In this segment we look at some of the...
Gold, Brent Crude spike as Israel strikes Iran in worst-case scenario Israel has come good on its threats to attack Iran on Friday morning, with strikes in Tehran reported by AP and Al Jazeera. Secondary but unconfirmed attacks have also been reported across X (formerly Twitter) today, too.Listen to the HotCopper podcast for in-depth discussions and insights on all...
Clinuvel shares dip, even as CEO comes back from temp leave After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...
Zip's stunning comeback: Is this the start of a $14 revival? Just when the market had written it off… Zip Co (ASX: ZIP) has come roaring back to life. The Buy Now, Pay Later company stunned investors last Wednesday with a 15% surge in its share price soon after upgrading its full-year earnings forecast to at least $160 million @ up from $153 million...

Featured News

NEWS Galactica Drilling Program Complete as Blue Star Transitions to Commercial Production
right-arrow Created with Sketch.
NEWS Anson Completes Maiden JORC Mineral Resources Estimate at Green River Lithium Project
right-arrow Created with Sketch.
NEWS Building Permits Received for Phase One Renewable Power Plant
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
NEWS Vection Launches Algho AI Sign Language on AWS Marketplace Across Europe
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.